New CFO at ROTOP – Dr. Michael Peterseim

New CFO at ROTOP – Dr. Michael Peterseim

We’re pleased to Welcome Dr. Michael Peterseim as our new Chief Financial Officer (CFO) at ROTOP

Dr. Peterseim brings many years of experience in financial leadership and has successfully guided companies through transformation processes, strengthened performance, and executed strategic transactions, particularly in growth situations. He has worked in various B2B and B2C environments, including in leadership roles at Roland Berger, KaDeWe Group, Camp David, Grundig, and Thomas Cook. Most recently, he joins us from QE-3 Equity Partners.
At ROTOP, Dr. Peterseim will be responsible for Finance/Controlling, HR, and IT/Technology and will support the next phase of our growth, with a particular focus on process optimization and new construction investments.

Dr. Michael Peterseim, Chief Financial Officer at ROTOP Pharmaka GmbH.

Ähnliche Beiträge

ROTOP Pharmaka Welcomes State Minister Dirk Panter: Radiopharmacy as a Key Technology in Modern Cancer Care

January 9th, 2026|

January 9, 2026 - ROTOP Pharmaka welcomed Saxony’s State Minister Dirk Panter during the region’s Radiopharmacy Theme Day. The exchange highlighted the importance of modern radiopharmacy for cancer care as well as ROTOP’s contribution through diagnostics, ready to use patient doses, and CDMO services, with a particular focus on theranostic concepts.

Go to Top